Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2019.13968
Abstract: This cohort study evaluates the feasibility and utility of incorporating comparative gene expression information into the precision medicine framework for difficult-to-treat pediatric and young adult patients with cancer. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.11079
Abstract: Key Points Question Is placement of an inferior vena cava filter associated with a lower rate of pulmonary embolism in patients with cancer and deep venous thrombosis? Findings In a population-based cohort study of 88 585… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2020.23121
Abstract: This quality improvement study examines the efficacy of a repeated testing protocol for coronavirus disease 2019 (COVID-19) among patients with cancer. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.50423
Abstract: Key Points Question Has there been a change in potentially preventable emergency department (ED) visits among adult patients with cancer over time? Findings In this cross-sectional study of 35.5 million ED visits among patients with… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2017.0762
Abstract: Importance Recently, tremendous prominence has been given to the investigation of the effect of different research processes as part of the Cancer Moonshot. More than half a century ago, the National Cancer Institute (NCI) established… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2019.0349
Abstract: This cross-sectional study analyzes the proportion of patients with cancer and cancer survivors who use complementary and alternative medicine (CAM) without disclosing this information to their physicians. read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2020.2548
Abstract: This case series examines the results of implementing a universal microbiologic screening strategy for asymptomatic patients with cancer for coronavirus disease 2019 at 1 institution in the United Arab Emirates. read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2020.6178
Abstract: Importance Patients with specific cancers may be at higher risk than those without cancer for coronavirus disease 2019 (COVID-19) and its severe outcomes. At present, limited data are available on the risk, racial disparity, and… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2021.2155
Abstract: Key Points Question Do patients with cancer develop adequate antibody responses to messenger RNA SARS-CoV-2 vaccines? Findings In this cohort study that included 102 patients with cancer who were receiving active treatment and 78 healthy… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2021.4318
Abstract: Importance There exists a paucity of literature that summarizes the effective management of cutaneous immune-related adverse events (cirAEs) in patients with cancer who are receiving immune checkpoint inhibitors (ICIs). Most published articles are small case… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.0001
Abstract: This cohort study investigates the immune response of patients with cancer to the first and second doses of the COVID-19 mRNA-1273 vaccination. read more here.